Find comprehensive information on lumpectomy, including clinical documentation requirements, medical coding guidelines (CPT, ICD-10), healthcare procedures, and post-operative care. Learn about breast conserving surgery, excisional biopsy, sentinel lymph node biopsy, and relevant pathology reports. This resource provides details on diagnosis, treatment, and recovery related to lumpectomy for healthcare professionals, coders, and patients seeking information.
Also known as
Excision of breast lesion
Removal of breast tissue, including lumpectomy.
In situ neoplasm of breast
Abnormal breast tissue growth often treated with lumpectomy.
Malignant neoplasm of breast
Breast cancer, for which lumpectomy may be a treatment option.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the lumpectomy for malignancy?
When to use each related code
| Description |
|---|
| Lumpectomy |
| Mastectomy |
| Sentinel node biopsy |
Missing or unclear documentation of margin status impacts code selection (e.g., 19120 vs. 19125), affecting reimbursement and quality reporting.
Incorrect coding or omission of sentinel lymph node biopsy (e.g., 38525) if performed with lumpectomy, leading to lost revenue.
Lack of clear documentation regarding laterality (left or right breast) can lead to coding errors and claim denials.
Q: What are the latest evidence-based guidelines for lumpectomy margin assessment in breast cancer surgery to minimize re-excision rates?
A: Current evidence-based guidelines, including those from the Society of Surgical Oncology (SSO) and the American Society of Clinical Oncology (ASCO), recommend no ink on tumor for invasive breast cancer lumpectomy margin assessment. This approach, focusing on obtaining negative margins (no ink on tumor) rather than a specific width of clear margin, has been shown to minimize re-excision rates without compromising local recurrence or overall survival. The SSO-ASTRO consensus guideline also highlights the importance of preoperative imaging and intraoperative specimen radiography to ensure complete tumor removal. Explore how these guidelines can be implemented in your practice to improve surgical outcomes and patient experience. Consider implementing standardized pathology reporting for better communication between surgeon and pathologist.
Q: How can I differentiate between various oncoplastic lumpectomy techniques to choose the most appropriate approach for individual patient cases, considering factors like tumor location, breast size, and desired cosmetic outcome?
A: Oncoplastic lumpectomy techniques encompass a range of procedures designed to achieve both oncological safety and optimal cosmetic results. Selection depends on factors like tumor location (e.g., upper outer quadrant vs. central), breast size and ptosis, patient body habitus, and desired cosmetic outcome. Techniques include volume displacement techniques (e.g., round block, mammaplasty techniques), and volume replacement techniques (e.g., lipofilling, LD flap). Each technique has its advantages and limitations regarding scar placement, potential complications, and suitability for different breast sizes and tumor locations. Understanding these nuances is crucial for tailoring the surgical approach to each patient. Learn more about the specific oncoplastic techniques and their respective indications to enhance your surgical decision-making.
Patient presents for lumpectomy procedure following a diagnosis of breast cancer. The patient's breast cancer diagnosis was confirmed by core needle biopsy demonstrating invasive ductal carcinoma, grade [insert grade]. Preoperative imaging including mammogram and breast ultrasound revealed a [size] cm mass located in the [location] quadrant of the [right/left] breast. No evidence of axillary lymphadenopathy was noted on physical exam or imaging. The patient underwent a lumpectomy with sentinel lymph node biopsy. Intraoperative frozen section analysis of the sentinel lymph nodes revealed [number] sentinel nodes, all negative for malignancy. The lumpectomy specimen margins were negative for residual carcinoma. Postoperative diagnosis: Invasive ductal carcinoma of the breast, status post lumpectomy and sentinel lymph node biopsy. The patient tolerated the procedure well and will follow up for discussion of adjuvant therapy options including radiation therapy and hormonal therapy, based on Oncotype DX results pending. Coding considerations include CPT codes for lumpectomy, sentinel lymph node biopsy, and intraoperative frozen section analysis. ICD-10 code for invasive ductal carcinoma of the breast should also be documented. This documentation supports medical necessity for breast cancer surgery, facilitates accurate medical billing, and informs ongoing cancer treatment planning.